"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
(Generic versions may still be available.)
Although anaphylactic reactions have not been reported with the Mono-Vacc®Test (O.T.), this remote possibility should be considered.
Although repeated testing of uninfected individuals does not sensitize to tuberculin, it may have a "booster" effect in persons with low levels of sensitivity to homologous or heterologous mycobacterial antigens.
The administration of adrenal corticosteroids or immunosuppressive drugs may decrease the intensity of or prevent a tuberculin reaction. Tuberculin sensitivity may decrease or disappear temporarily as a result of febrile illness; measles and other exanthemas; live virus vaccination; sarcoidosis and miliary or pulmonary tuberculosis.
Reproductive Studies — Category C: Animal reproduction studies have not been conducted with Tuberculin, Old Mono-Vacc ®Test (O.T.). It is also not known whether Tuberculin, Old can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Tuberculin, Old should be given to a pregnant woman only if clearly needed.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Mono-Vacc Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.